ECTS credits ECTS credits: 3
ECTS Hours Rules/Memories Student's work ECTS: 51 Hours of tutorials: 3 Expository Class: 9 Interactive Classroom: 12 Total: 75
Use languages Spanish, Galician
Type: Ordinary subject Master’s Degree RD 1393/2007 - 822/2021
Departments: Pharmacology, Pharmacy and Pharmaceutical Technology
Areas: Pharmacy and Pharmaceutical Technology
Center Faculty of Pharmacy
Call: Second Semester
Teaching: With teaching
Enrolment: Enrollable | 1st year (Yes)
Getting adequate and practical knowledge about the materials used in pharmaceutical technology, its overall classification, its processing, and its fundamental properties. A primary goal of the course is to develop the student's ability to provide solutions to technical problems related to biomaterials and pharmaceutical technology.
Theme block 1. Excipients and their application in pharmacy: inorganic materials, lipid materials, natural and synthetic polymeric materials.
Theme block 2. Physico-chemical properties of the materials and techniques for their characterization: particle size, morphology, hydrophilicity, swelling, self-assembly.
Theme block 3. Interaction of materials with the biological environment and the techniques for their characterization, including: (bio-)degradation, protein adsorption, biocompatibility and other biological functions.
1. Pharmaceutical dosage forms. Tablets., 3rd Ed., Larry L. Augsburger, Stephen W. Hoag, New York: Informa Healthcare, 2008.
2. Encyclopedia of pharmaceutical technology. James Swarbrick, James C. Boylan Eds., New York: Marcel Dekker, 1998.
3. Polymeric biomaterials, 2nd ed., Severian Dumitriu Ed., New York: Marcel Dekker, 2002.
4. Biomaterials and bioengineering handbook, Donald L. Wise Ed., New Cork: Marcel Dekker, 2000.
5. Biomaterials engineering and devices : human applications, Donald L. Wise Ed.,
Totowa (New Jersey): Humana Press, 2000.
6. Handbook of pharmaceutical excipients, 5th ed, Raymond C. Rowe, Paul J. Sheskey, Sian C. Owen Eds., London: Pharmaceutical Press; Washington: American Pharmaceutical Association, 2006.
7. S. Piletsky, Molecular imprinting of polymers, Sergey Piletsky, Anthony Turner Ed., Georgetown: Landes Bioscience: Eurekah.com, 2006.
8. Methods of tissue engineering, Anthony Atala, Robert P. Lanza Eds., San Diego: Academic Press, 2002.
Learning objectives:
- Have a general knowledge of the materials commonly used in pharmaceutical applications.
CB1, CB2, CB3, CB5, CG1, CG2, CG3, CG11, CE1, CE2, CE3, CE8, CE15
- Understand the physico-chemical properties and the biological interactions of materials and the main methods for its characterization.
CB1, CB2, CB5, CG1, CG2, CG11, CE1, CE2, CE3, CE8
- Develop the ability to rationally select materials for their use in various pharmaceutical applications.
CB1, CB2, CB5, CG1, CG2, CG11, CE1, CE2, CE3, CE8
- Develop the ability to solve problems.
CB1, CB2, CB3, CB4, CB5, CG2, CG5, CG7, CG10, CG11, CE3, CE6, CE8, CE11, CE15
- Develop the capacity for individual and team work.
CB2, CB4, CB5, CG4, CG7, CG8, CG9, CE5, CE6, CE14, CE15
- Develop the ability to communicate in different settings: presentations, brainstorming, teamwork.
CB2, CB4, CG3, CG5, CG6, CG8, CG10, CE6, CE13, CE14
• Lectures:
PowerPoint presentations, which will provide the student previously used.
• Seminars:
Specific issues will be presented to promote discussion of the students.
Others will be dedicated to the exhibition of works by students.
The teaching material (program, presentations, seminars, bibliographic material for seminars ... etc) will be provided to students periodically, before classes and seminars
a) Lectures
Face to face lectures will be combine with 10% of telematics classes (Scenario 1); and in virtual synchronous classes (Virtual Campus-Moodle and MS Teams) (Scenarios 2 and 3).
b) Interactive Classes and Tutorials
The Interactive Classes will be face-to-face (Scenarios 1 and 2) and in synchronous telematics mode (Virtual Campus-Moodle and MS Teams) (Scenario 3).
The Tutorials may be face-to-face / telematics in scenario 1 and 2 and telematics in scenario 3
Continuous assessment will be carried out throughout the course, complemented with a specific final exam.
Whenever possible, the evaluation will be carried out face to face (Scenario I and 2). Evaluation will be virtual synchronous (Virtual Campus-Moodle, MS Teams, MS Forms) for scenario 3.
Continuous evaluation (80%)
• Students must compulsorily participate in presentations during the seminars, after the selection of a topic in agreement with the teachers. The quality of the presentation will represent 50% of the final score (content of the work 30%, exposition 10%, and defense 10%).
• Continuous assessment (30 % of the final score): attendance at lectures and seminars is mandatory. It will take into account the participation / involvement of the student throughout the course.
Specific final test (20%)
• The evaluation of the theoretical contents will be completed with an exam, which will represent 20% of the final grade. The pass will be in 5 out of 10. The exam will consist of test and / or short questions.
Materials (program, presentations, seminars, literature for the seminars ... etc.) will be provided to students periodically, before classes and seminars
Teaching hours: 30 h.
Student work hours: 45 h.
ECTS credits: 3.
Intermediate English level or better.
In Scenario 2, exams will be perfomed either in presence or by telematic means, depending on the sanitary situation.
In case of fraudulent actions during examination or tests, the specific rules established by Regulation for the evaluation, qualification and revision of academic performance will be applied.
Marcos Garcia Fuentes
- Department
- Pharmacology, Pharmacy and Pharmaceutical Technology
- Area
- Pharmacy and Pharmaceutical Technology
- Phone
- 881815450
- marcos.garcia [at] usc.es
- Category
- Professor: University Lecturer
Noemi Stefania Csaba
Coordinador/a- Department
- Pharmacology, Pharmacy and Pharmaceutical Technology
- Area
- Pharmacy and Pharmaceutical Technology
- noemi.csaba [at] usc.es
- Category
- Professor: University Lecturer
| Monday | |||
|---|---|---|---|
| 16:30-18:30 | Grupo /CLE_01 | Spanish | 5035 Bromatology Seminar Room |
| 18:30-19:30 | Grupo /CLIS_01 | Spanish | 5035 Bromatology Seminar Room |
| Tuesday | |||
| 16:30-18:30 | Grupo /CLE_01 | Spanish | 5035 Bromatology Seminar Room |
| 18:30-19:30 | Grupo /CLIS_01 | Spanish | 5035 Bromatology Seminar Room |
| Wednesday | |||
| 16:30-18:30 | Grupo /CLE_01 | Spanish | 5035 Bromatology Seminar Room |
| 18:30-19:30 | Grupo /CLIS_01 | Spanish | 5035 Bromatology Seminar Room |
| Thursday | |||
| 16:30-18:30 | Grupo /CLE_01 | Spanish | 5035 Bromatology Seminar Room |
| 18:30-19:30 | Grupo /CLIS_01 | Spanish | 5035 Bromatology Seminar Room |